Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-26

FDA Approved: MERCAPTOPURINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for mercaptopurine, enabling continued marketing of the generic product under an appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mercaptopurine (Mercaptopurine)

Snippet

SUPPL AP for MERCAPTOPURINE (MERCAPTOPURINE)